Large-vessel occlusion stroke after cardiothoracic surgery: Expanding time windows offer new salvage opportunities.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
07 2019
Historique:
received: 08 03 2018
revised: 09 10 2018
accepted: 25 11 2018
pubmed: 28 1 2019
medline: 26 2 2020
entrez: 28 1 2019
Statut: ppublish

Résumé

Ischemic stroke due to large-vessel occlusion (LVO) is a complication after cardiothoracic surgery (CTS). Recently published endovascular stroke trials have major implications for treating LVO strokes; we evaluated our experience in patients undergoing CTS. Our prospective institutional CTS database was reviewed between July 2013 and April 2018 for ischemic strokes. Patients with LVO were identified and their course and outcomes analyzed. A total of 5947 patients were reviewed; 148 (2.48%) had a cerebrovascular complication; 92.5% were ischemic. Of these 10.9% had an LVO. Prolonged aortic crossclamp was associated with LVO (odds ratio, 1.012 for every minute of prolonged aortic crossclamp time; confidence interval, 1.001-1.023) and remained significant in patients with ejection fraction >45%; prolonged cardiac bypass time was only associated with LVO in patients with ejection fraction >45% (odds ratio, 1.012 for every minute of prolonged cardiac bypass time; confidence interval, 1.003-1.021). Patients fell into 2 categories: detection of neurologic deficit in the stable postoperative patient or detection of deficit on emergence from anesthesia. Seven patients met criteria for emergent revascularization, with median National Institutes of Health Stroke Scale score 15, and shorter times from last seen well to deficit detection compared with patients not meeting criteria (P = .032). Median National Institutes of Health Stroke Scale day 7 score improved to 5. There was a trend toward better modified Rankin Scale scores at 3 months in patients who underwent thrombectomy. LVO complicates a small proportion of patients after CTS and may be more likely with prolonged aortic crossclamp and cardiac bypass times. Both early and late window endovascular stroke treatment has the potential to positively modify the complication profile of CTS. Greater awareness of this treatment option is needed.

Identifiants

pubmed: 30685180
pii: S0022-5223(18)33256-2
doi: 10.1016/j.jtcvs.2018.11.106
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-196.e2

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Faheem Sheriff (F)

Neurocritical Care, Department of Neurology, Massachusetts General Hospital, Boston, Mass.

Joshua Hirsch (J)

Neuroradiology, Department of Radiology, Massachusetts General Hospital, Boston, Mass.

Kenneth Shelton (K)

Cardiac Critical Care, Department of Anesthesia, Massachusetts General Hospital, Boston, Mass.

David D'Alessandro (D)

Cardiothoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Mass.

Chris Stapleton (C)

Neuroendovascular, Department of Neurosurgery, Massachusetts General Hospital, Boston, Mass.

Matthew Koch (M)

Neuroendovascular, Department of Neurosurgery, Massachusetts General Hospital, Boston, Mass.

James Rabinov (J)

Neuroendovascular, Department of Neurosurgery, Massachusetts General Hospital, Boston, Mass.

Arminder Jassar (A)

Cardiothoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Mass.

Aman Patel (A)

Neuroendovascular, Department of Neurosurgery, Massachusetts General Hospital, Boston, Mass.

Thabele Leslie-Mazwi (T)

Neurocritical Care, Department of Neurology, Massachusetts General Hospital, Boston, Mass; Neuroendovascular, Department of Neurosurgery, Massachusetts General Hospital, Boston, Mass. Electronic address: tleslie-mazwi@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH